“…First of all, it would give access to a variety of imidazo[1,2- a ]-heterocycles, including, the privileged scaffold imidazo[1,2- a ]pyridine, a well-known moiety in many marketed drugs, such as zolpidem, minodronic acid, etc. 52 Secondly, we hypothesized that our recently developed isocyano alkyl tosylates 1a–c in a GBB-3CR 53 can constitute an excellent mode I-substrate 11 with a nucleophilic center (X δ − , highlighted in cyan), which triggers the CO 2 incorporation, combined with an electrophilic site (LG δ + , highlighted in green) (Scheme 1D).…”